Emily Chan

Company: Amgen

Job title: Executive Director – Oncology Global Development

Seminars:

Advancing Liquid Biopsy Applications for RAS-Mutant Cancers to Optimize Targeted Therapy Strategies 1:30 pm

How can liquid biopsy improve the detection and monitoring of RAS mutations to guide targeted therapy decisions? What challenges exist in standardizing ctDNA assays for RAS mutation detection across different tumor types and treatment settings? How can longitudinal liquid biopsy analysis help track treatment resistance and identify emerging RAS-driven escape mechanisms? RAS-MutantRead more

day: Conference Day 2